
Where GLP-1 Peptides Go Missing: Protecting Recovery From Vial to Column
Episodes in this series

This segment shifts from separation strategy to a more practical concern: how sample handling and instrument hardware choices can silently distort peptide analysis results. Sam Whitmarsh asks Nitish Sharma how his lab optimizes chromatographic systems and sample handling to ensure that observed peaks reflect the true sample rather than artifacts introduced by a suboptimal setup. Sharma ties the mobile-phase pH selection back to the peptide's pI value, and explains the role of the high performance liquid chromatography (HPLC) index—a measure of hydrophobicity—in determining how much organic solvent is needed in both the mobile phase and diluent. Because GLP-1 analogs carry long carbon chains that add hydrophobicity to the peptide backbone, getting this ratio right is essential for sharp, well-separated peaks. He also recommends wide-pore, 300-angstrom columns for better stationary-phase interaction and retention.
Sharma raises a less obvious risk: peptide loss to plastic and glass surfaces during handling, since many peptides are zwitterionic and prone to nonspecific adsorption onto tubing, vials, and even plastic-lined tubes. His practical fix is to use appropriate ionic buffers in the diluent—such as dilute sodium chloride or acetate—and, where possible, to mimic the peptide's own formulation buffer, since it has typically already been optimized by formulators to stabilize the molecule.
Piotr Alvarez adds a hardware-focused perspective, describing a head-to-head comparison his team ran between inert and non-inert column housings for a GLP-1 hydrophilic interaction liquid chromatography (HILIC) method. The non-inert hardware showed substantially lower recovery, a finding with real consequences, Alvarez notes, since if recovery loss is visible at the active pharmaceutical ingredient (API) level, smaller impurity peaks could be masked or missed entirely. He also flags that peptides tend to degrade on-column at elevated temperatures, meaning method developers must balance column temperature against mobile-phase pH, and separately verify whether that degradation risk changes with inert vs. standard hardware.
Related to this article











